BTX · Categories · 8-K

BTX - SEC Form 8-K filings

BlackRock Technology and Private Equity Term Trust (BTX) sec form 8-k filings - real-time wire coverage filtered to 8-K only.

Recent 8-K for BTX

846d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
873d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
903d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Leadership Update, Other Events, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
909d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
937d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
953d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
979d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Other Events
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
988d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update (Amendment)
8-K/A - Eterna Therapeutics Inc. (0000748592) (Filer)
1014d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1035d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1043d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1059d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1064d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1065d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1086d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1133d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1135d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1157d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1178d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1204d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1231d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1247d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1253d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1282d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1284d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1294d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1296d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1296d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1309d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1325d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
8-K - Eterna Therapeutics Inc. (0000748592) (Filer)
1335d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1339d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1356d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1364d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1378d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits (Amendment)
8-K/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1405d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1414d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1440d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1454d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1464d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1472d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1513d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1517d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1554d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1598d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1603d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1618d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1632d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1661d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Other Events
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1672d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1700d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1713d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)
8-K/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1721d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1724d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1731d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1732d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1736d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1755d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1758d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)
1787d
Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Filer)

BTX - SEC Form 8-K filings

Recent 8-K for BTX

Other BTX categories